Eli Lilly's insulin gets EU backing
Pharma firm Eli Lilly was backed in Europe this week in its bid to make a generic version of French firm Sanofi's Lantus insulin. The decision by European regulators paves the way for Eli Lilly, which has operations at four Irish locations, to produce the first copycat version of the French firm's best-selling medicine.
Last Friday, Eli Lilly's Abasria insulin was recommended by the European Medicines Agency's committee for...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team